Transcardiac increase in tumor necrosis factor-alpha and left ventricular end-diastolic volume in patients with dilated cardiomyopathy.

Takayoshi Tsutamoto,Tomoyuki Takayama,Atsuyuki Wada,Takashi Tsutsui,Masanori Fujii,Chitose Ishii,Minoru Horie,Keijin Ohno,Takehiro Matsumoto,Takashi Yamamoto,Tomohiro Dohke,Masato Ohnishi

doi:10.1016/j.ejheart.2003.10.004

Takayoshi Tsutamoto, Tomoyuki Takayama + Show 10 more

Open Access

https://doi.org/10.1016/j.ejheart.2003.10.004

Copy DOI

Abstract

It remains unclear whether tumor necrosis factor (TNF)-alpha and interleukin-6 (IL-6) are secreted from the failing heart and whether there is a relationship between the transcardiac gradients of these cytokines and left ventricular (LV) remodeling. This study evaluated the relationship between transcardiac gradients of cytokines and LV volume and function in congestive heart failure patients with dilated cardiomyopathy (DCM). We measured the plasma levels of TNF-alpha and IL-6 in the aortic root (Ao) and the coronary sinus (CS) in 60 patients with DCM. There was no difference in plasma IL-6 between the Ao and the CS. However, the plasma TNF-alpha level was significantly higher in the CS than that in the Ao. There was a significant correlation between the transcardiac gradient of plasma TNF-alpha and the LV end-diastolic volume index (LVEDVI) and LV ejection fraction. According to stepwise multivariate analyses, the transcardiac increase of TNF-alpha showed an independent and significantly positive relationship with a large LVEDVI. These results indicate that the elevated plasma TNF-alpha is partly derived from the failing heart in patients with DCM and that TNF-alpha plays a potential role in structural LV remodeling in patients with DCM.

Full Text